Opinion Piece: The case for establishing a minimal medication alternative for psychosis and schizophrenia

Ruth E. Cooper, John P. Mason, Tim Calton, John Richardson and Joanna Moncrieff

Psychosis, 2021, vol. 13, issue 3, 276-285

Abstract: The development of severe mental health conditions is strongly linked to our environments, particularly experiences of trauma and adversity. However treatments for severe mental health conditions are often primarily biomedical, centred around medication. For people diagnosed with schizophrenia or psychosis, this is antipsychotic medication. Although antipsychotics have been found to reduce symptoms and risk of relapse, some patients derive little benefit from these drugs, and they can lead to severe adverse effects. Subsequently, a high proportion of people do not want to take antipsychotics and request an alternative. Yet in the UK and in many countries there are currently no guidelines for stopping antipsychotics or formal treatment alternatives, despite such alternatives being available in some countries. For example, in Norway and Vermont (USA), in response to pressure from service user organisations, governments have mandated the establishment of “minimal medication” services. We examine whether everyone with a psychotic condition needs long-term antipsychotic treatment and evidence for alternative models of care. We recommend that healthcare providers should be encouraged to develop a psychosocial treatment package for people with psychosis or schizophrenia that provides a realistic possibility of minimising antipsychotic exposure.

Date: 2021
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://hdl.handle.net/10.1080/17522439.2021.1930119 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:rpsyxx:v:13:y:2021:i:3:p:276-285

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/RPSY20

DOI: 10.1080/17522439.2021.1930119

Access Statistics for this article

Psychosis is currently edited by Dr John Read

More articles in Psychosis from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().